124 related articles for article (PubMed ID: 31778303)
21. Plasminogen Deficiency Delays the Onset and Protects from Demyelination and Paralysis in Autoimmune Neuroinflammatory Disease.
Shaw MA; Gao Z; McElhinney KE; Thornton S; Flick MJ; Lane A; Degen JL; Ryu JK; Akassoglou K; Mullins ES
J Neurosci; 2017 Apr; 37(14):3776-3788. PubMed ID: 28275164
[TBL] [Abstract][Full Text] [Related]
22. CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells.
Chung CY; Liao F
J Neuroinflammation; 2016 Apr; 13(1):76. PubMed ID: 27068264
[TBL] [Abstract][Full Text] [Related]
23. Polymerase I pathway inhibitor ameliorates experimental autoimmune encephalomyelitis.
Achiron A; Mashiach R; Zilkha-Falb R; Meijler MM; Gurevich M
J Neuroimmunol; 2013 Oct; 263(1-2):91-7. PubMed ID: 23998422
[TBL] [Abstract][Full Text] [Related]
24. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
[TBL] [Abstract][Full Text] [Related]
25. Tissue Transglutaminase contributes to experimental multiple sclerosis pathogenesis and clinical outcome by promoting macrophage migration.
van Strien ME; de Vries HE; Chrobok NL; Bol JGJM; Breve JJP; van der Pol SMP; Kooij G; van Buul JD; Karpuj M; Steinman L; Wilhelmus MM; Sestito C; Drukarch B; Van Dam AM
Brain Behav Immun; 2015 Nov; 50():141-154. PubMed ID: 26133787
[TBL] [Abstract][Full Text] [Related]
26. RGS10 deficiency ameliorates the severity of disease in experimental autoimmune encephalomyelitis.
Lee JK; Kannarkat GT; Chung J; Joon Lee H; Graham KL; Tansey MG
J Neuroinflammation; 2016 Feb; 13():24. PubMed ID: 26831924
[TBL] [Abstract][Full Text] [Related]
27. β-Caryophyllene ameliorates the development of experimental autoimmune encephalomyelitis in C57BL/6 mice.
Fontes LBA; Dias DDS; Aarestrup BJV; Aarestrup FM; Da Silva Filho AA; Corrêa JODA
Biomed Pharmacother; 2017 Jul; 91():257-264. PubMed ID: 28463791
[TBL] [Abstract][Full Text] [Related]
28. Daphnetin Alleviates Experimental Autoimmune Encephalomyelitis via Regulating Dendritic Cell Activity.
Wang D; Lu Z; Zhang H; Jin SF; Yang H; Li YM; Shi LY
CNS Neurosci Ther; 2016 Jul; 22(7):558-67. PubMed ID: 27013083
[TBL] [Abstract][Full Text] [Related]
29. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice.
Hu X; Qin X
Int J Mol Med; 2013 May; 31(5):1209-21. PubMed ID: 23525227
[TBL] [Abstract][Full Text] [Related]
30. Caspase-1 regulates the inflammatory process leading to autoimmune demyelination.
Furlan R; Martino G; Galbiati F; Poliani PL; Smiroldo S; Bergami A; Desina G; Comi G; Flavell R; Su MS; Adorini L
J Immunol; 1999 Sep; 163(5):2403-9. PubMed ID: 10452974
[TBL] [Abstract][Full Text] [Related]
31. Staphylococcus aureus α-Toxin Induces Inflammatory Cytokines via Lysosomal Acid Sphingomyelinase and Ceramides.
Ma J; Gulbins E; Edwards MJ; Caldwell CC; Fraunholz M; Becker KA
Cell Physiol Biochem; 2017; 43(6):2170-2184. PubMed ID: 29069651
[TBL] [Abstract][Full Text] [Related]
32. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP
Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850
[TBL] [Abstract][Full Text] [Related]
33. CD24 on the resident cells of the central nervous system enhances experimental autoimmune encephalomyelitis.
Liu JQ; Carl JW; Joshi PS; RayChaudhury A; Pu XA; Shi FD; Bai XF
J Immunol; 2007 May; 178(10):6227-35. PubMed ID: 17475850
[TBL] [Abstract][Full Text] [Related]
34. Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.
Souza PS; Gonçalves ED; Pedroso GS; Farias HR; Junqueira SC; Marcon R; Tuon T; Cola M; Silveira PCL; Santos AR; Calixto JB; Souza CT; de Pinho RA; Dutra RC
Mol Neurobiol; 2017 Aug; 54(6):4723-4737. PubMed ID: 27447807
[TBL] [Abstract][Full Text] [Related]
35. Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis.
Forte M; Gold BG; Marracci G; Chaudhary P; Basso E; Johnsen D; Yu X; Fowlkes J; Rahder M; Stem K; Bernardi P; Bourdette D
Proc Natl Acad Sci U S A; 2007 May; 104(18):7558-63. PubMed ID: 17463082
[TBL] [Abstract][Full Text] [Related]
36. Exercise training attenuates experimental autoimmune encephalomyelitis by peripheral immunomodulation rather than direct neuroprotection.
Einstein O; Fainstein N; Touloumi O; Lagoudaki R; Hanya E; Grigoriadis N; Katz A; Ben-Hur T
Exp Neurol; 2018 Jan; 299(Pt A):56-64. PubMed ID: 29031957
[TBL] [Abstract][Full Text] [Related]
37. CD4+ Foxp3+ regulatory T cell-mediated immunomodulation by anti-depressants inhibiting acid sphingomyelinase.
Schneider-Schaulies J; Beyersdorf N
Biol Chem; 2018 Sep; 399(10):1175-1182. PubMed ID: 29908119
[TBL] [Abstract][Full Text] [Related]
38. The Role of Acid Sphingomyelinase Inhibition in Repetitive Mild Traumatic Brain Injury.
Niziolek GM; Hoehn RS; Seitz AP; Jernigan PL; Makley AT; Gulbins E; Edwards MJ; Goodman MD
J Surg Res; 2021 Mar; 259():296-304. PubMed ID: 33131764
[TBL] [Abstract][Full Text] [Related]
39. Diminished cytokine and chemokine expression in the central nervous system of GMF-deficient mice with experimental autoimmune encephalomyelitis.
Zaheer A; Sahu SK; Wu Y; Zaheer A; Haas J; Lee K; Yang B
Brain Res; 2007 May; 1144():239-47. PubMed ID: 17316572
[TBL] [Abstract][Full Text] [Related]
40. Collagenase-2 deficiency or inhibition impairs experimental autoimmune encephalomyelitis in mice.
Folgueras AR; Fueyo A; García-Suárez O; Cox J; Astudillo A; Tortorella P; Campestre C; Gutiérrez-Fernández A; Fanjul-Fernández M; Pennington CJ; Edwards DR; Overall CM; López-Otín C
J Biol Chem; 2008 Apr; 283(14):9465-74. PubMed ID: 18245084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
